AJP - Renal Physiology, Vol 264, Issue 5 917-F922, Copyright © 1993 by American Physiological Society

ARTICLES

Effects of IGF-I on renal function in patients with chronic renal failure

M. H. O'Shea, S. B. Miller and M. R. Hammerman
Department of Internal Medicine, George M. O'Brien Kidney and Urological Diseases Center, Washington University School of Medicine, St. Louis, Missouri 63110.

Insulin-like growth factor I (IGF-I) has been shown to increase glomerular filtration rate and renal plasma flow in rats and humans with normal renal function. However, rats with reduced renal function are resistant to these effects. To determine whether IGF-I affects glomerular filtration rate and renal plasma flow in humans with reduced renal function, we administered recombinant human IGF-I (rhIGF-I) to patients with moderate chronic renal failure. Four patients whose baseline inulin clearances were 21.9, 23.2, 34.9, and 55.1 ml.min-1.1.73 m-2 were placed on a 1 g.kg-1.day-1 protein diet and studied over a 10-day period (0-10). On days 4-7, 100 micrograms/kg of rhIGF-I was subcutaneously administered twice daily to the patients. The effects of rhIGF-I on levels of circulating IGF-I, inulin clearance, p-aminohippurate (PAH) clearance, kidney volume, plasma glucose, plasma and urine calcium and phosphate, and urine sodium and protein were determined. Administration of rhIGF-I increased levels of circulating IGF-I, inulin clearances, PAH clearances, and kidney size in each of the four patients receiving the growth factor. IGF-I did not cause weight gain, natriuresis, proteinuria, or hypoglycemia. Plasma calcium and phosphate were not affected by rhIGF-I. However, the percent tubular reabsorption of filtered phosphate was increased. We conclude that administration of rhIGF-I can enhance glomerular filtration rate and renal plasma flow at least in some humans with moderately reduced renal function. The enhancement is associated with an increase in kidney volume.

This article has been cited by other articles:

				V. ROELFSEMA and R. G. CLARK The Growth Hormone and Insulin-Like Growth Factor Axis: Its Manipulation for the Benefit of Growth Disorders in Renal Failure J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1297 - 1306. [Abstract] [Full Text]

				M. R. Hammerman `The growth hormone–insulin-like growth factor axis in kidney re-revisited Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1853 - 1860. [Full Text] [PDF]

				A. Vijayan, S. C. Franklin, T. Behrend, M. R. Hammerman, and S. B. Miller Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failure Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R929 - R934. [Abstract] [Full Text] [PDF]

				A. Sandra, M. Boes, B. L. Dake, J. B. Stokes, and R. S. Bar Infused IGF-I/IGFBP-3 complex causes glomerular localization of IGF-I in the rat kidney Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E32 - E37. [Abstract] [Full Text] [PDF]